2008
Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City
Amesty S, Ompad D, Galea S, Fuller C, Wu Y, Koblin B, Vlahov D. Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City. Journal Of Community Health 2008, 33: 139-148. PMID: 18185987, DOI: 10.1007/s10900-007-9082-4.Peer-Reviewed Original ResearchConceptsEvidence of infectionHBV vaccinationPrevious vaccinationSerological evidenceHepatitis B vaccination coveragePrevious hepatitis B vaccinationPrevious HBV infectionPrevious HBV vaccinationHepatitis B vaccinationHepatitis B vaccineHigh-risk groupYears of ageCommunity-based sampleB vaccinationHBV infectionB vaccineVaccination statusVaccination coverageRisk groupsHigh school educationVaccinationSusceptible individualsDrug usersInfection rateBivariate analysis
2005
Ecstasy Use Among Hispanic and Black Substance Users in New York City
Ompad D, Galea S, Fuller C, Edwards V, Vlahov D. Ecstasy Use Among Hispanic and Black Substance Users in New York City. Substance Use & Misuse 2005, 40: 1399-1407. PMID: 16048824, DOI: 10.1081/ja-200066960.Peer-Reviewed Original Research
2004
The Social Epidemiology of Substance Use
Galea S, Nandi A, Vlahov D. The Social Epidemiology of Substance Use. Epidemiologic Reviews 2004, 26: 36-52. PMID: 15234946, DOI: 10.1093/epirev/mxh007.Peer-Reviewed Original Research
2003
Social Circumstances of Initiation of Injection Drug Use and Early Shooting Gallery Attendance: Implications for HIV Intervention Among Adolescent and Young Adult Injection Drug Users
Fuller C, Vlahov D, Latkin C, Ompad D, Celentano D, Strathdee S. Social Circumstances of Initiation of Injection Drug Use and Early Shooting Gallery Attendance: Implications for HIV Intervention Among Adolescent and Young Adult Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2003, 32: 86. PMID: 12514419, DOI: 10.1097/00126334-200301010-00013.Peer-Reviewed Original ResearchConceptsInjection drug usersNew injection drug usersOlder injection drug usersYoung adult injection drug usersDrug usersHigh-risk injection drug usersStreet-recruited injection drug usersAdult injection drug usersYoung injection drug usersGallery attendanceProspective cohort studyInjection drug useMultiple logistic regressionHigh-risk practicesCohort studyMedian ageHIV incidenceHIV prevalenceInnovative intervention strategiesHIV interventionsDrug useLogistic regressionHIVBaseline dataMost participants
2001
Factors Associated with Adolescent Initiation of Injection Drug Use
Fuller C, Vlahov D, Arria A, Ompad D, Garfein R, Strathdee S. Factors Associated with Adolescent Initiation of Injection Drug Use. Public Health Reports 2001, 116: 136-145. PMID: 11889281, PMCID: PMC1913680, DOI: 10.1093/phr/116.s1.136.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdolescent BehaviorAdultAge FactorsBaltimoreBlack or African AmericanCommunity-Institutional RelationsFemaleHealth BehaviorHepatitis CHIV InfectionsHumansLogistic ModelsMalePrimary PreventionProspective StudiesRisk AssessmentRisk-TakingSexual BehaviorSubstance Abuse, IntravenousConceptsInjection drug useDrug useMedian ageInitiation of injectionCrack smokingNon-injection drug useAdolescent initiationHigh-risk groupYears of ageIllicit drug useAfrican AmericansDrug use practicesStudy enrollmentPrevents onsetEarly prevention effortsDrug usersMultivariate analysisCocaine useCondom useSmoking marijuanaLogistic regressionYoung drug usersPrevention effortsYoung adulthoodSmokingFactors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City
Diaz T, Des Jarlais D, Vlahov D, Perlis T, Edwards V, Friedman S, Rockwell R, Hoover D, Williams I, Monterroso E. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal Of Public Health 2001, 91: 23-30. PMID: 11189819, PMCID: PMC1446499, DOI: 10.2105/ajph.91.1.23.Peer-Reviewed Original ResearchConceptsInjection drug usersYoung adult injection drug usersAdult injection drug usersHepatitis B virusDrug usersHCV infectionPrevalent hepatitis C virus infectionHepatitis C virus infectionYoung injection drug usersAnti-HCV positivityPrevalent HCV infectionPrevalent hepatitis CC virus infectionHIV serologyHCV antibodiesHepatitis CB virusVirus infectionDrug treatmentDrug useHCVNew York CitySex practicesInfectionUpper Manhattan
1999
Longitudinal Human Immunodeficiency Virus Type 1 Load in the Italian Seroconversion Study: Correlates and Temporal Trends of Virus Load
Lyles C, Dorrucci M, Vlahov D, Pezzotti P, Angarano G, Sinicco A, Alberici F, Alcorn T, Vella S, Rezza G. Longitudinal Human Immunodeficiency Virus Type 1 Load in the Italian Seroconversion Study: Correlates and Temporal Trends of Virus Load. The Journal Of Infectious Diseases 1999, 180: 1018-1024. PMID: 10479126, DOI: 10.1086/314980.Peer-Reviewed Original ResearchConceptsHIV-1 loadVirus loadHuman immunodeficiency virus type 1 (HIV-1) loadHuman immunodeficiency virus type 1 (HIV-1) seroconvertersCD4 cells/microL.Low CD4 cell countsItalian Seroconversion StudyCD4 cell countCells/microL.Injection drug useCourse of diseaseReverse transcriptase-polymerase chain reactionHigh virus loadTranscriptase-polymerase chain reactionClinical AIDSMale sexProspective studyDisease progressionSeroconversion StudyCell countDrug useSustained increaseSeroconversionAIDSFrozen serumHIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old
Carneiro M, Fuller C, Doherty M, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug And Alcohol Dependence 1999, 54: 83-86. PMID: 10101620, DOI: 10.1016/s0376-8716(98)00142-2.Peer-Reviewed Original ResearchConceptsInjection drug usersInjection drug useRisk behaviorsDrug usersDrug useCross-sectional studyRates of HIVHigh-risk behaviorsAge of initiationHIV infectionHIV prevalenceFirst injectionWide age rangeAverage ageNew initiatesHygiene practicesAge rangeAgeRecruitment techniquesInjectionYearsHIVInitiationInfectionPrevalence
1998
Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk Groups
Lyles C, Vlahov D, Farzadegan H, Astemborski J, Margolick J, Masters B, Schroeder J, Quinn T. Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk Groups. Journal Of Clinical Microbiology 1998, 36: 3647-3652. PMID: 9817889, PMCID: PMC105256, DOI: 10.1128/jcm.36.12.3647-3652.1998.Peer-Reviewed Original ResearchConceptsInfectious viral loadInjection drug usersHIV RNA levelsHIV RNA loadViral loadRisk groupsRNA loadViral burdenHuman immunodeficiency virus type 1 (HIV-1) loadHomosexual menPlasma HIV RNA levelsMale injection drug usersFemale injection drug usersHuman immunodeficiency virus type 1Peripheral blood mononuclear cellsImmunodeficiency virus type 1RNA levelsBlood mononuclear cellsHIV risk groupViral RNA loadVirus type 1HIV loadMononuclear cellsDrug usersCell count
1996
Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion
Pezzotti P, Phillips A, Dorrucci M, Lepri A, Galai N, Vlahov D, Rezza G. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. The BMJ 1996, 313: 583. PMID: 8806246, PMCID: PMC2352019, DOI: 10.1136/bmj.313.7057.583.Peer-Reviewed Original ResearchConceptsDate of seroconversionCategories of exposureExposure categoriesOlder subjectsInjected drugsMore rapid progressionHeterosexual sexLongitudinal studyHomosexual sexHIV treatmentAIDS pathogenesisUnivariate analysisRapid progressionAge effectsYoung subjectsHomosexual menHIVRate of developmentEvidence of differencesDisease controlAIDSSeroconversionSexAgeDefinitions of Center
1995
Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users
Semba R, Caiaffa W, Graham N, Cohn S, Vlahov D. Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users. The Journal Of Infectious Diseases 1995, 171: 1196-1202. PMID: 7751694, DOI: 10.1093/infdis/171.5.1196.Peer-Reviewed Original ResearchConceptsInjection drug usersHuman immunodeficiency virus-infected injection drug usersDrug usersPredictors of mortalityLarge prospective cohortBody mass indexHuman immunodeficiency virusCase-control studyPlasma vitamin ACD4 cellsProspective cohortHIV infectionIndependent predictorsMass indexImmunodeficiency virusLast visitRisk factorsHigh riskVitamin AAdult subjectsMortalityInfectionMean lengthWastingVitaminNormative Data for a Brief Neuropsychologic Test Battery in a Cohort of Injecting Drug Users
Concha M, Seines O, McArthur J, Nance-Sproson T, Updike M, Royal W, Solomon L, Vlahov D. Normative Data for a Brief Neuropsychologic Test Battery in a Cohort of Injecting Drug Users. Substance Use & Misuse 1995, 30: 823-841. PMID: 7558472, DOI: 10.3109/10826089509067009.Peer-Reviewed Original Research
1994
Validation of the proposed World Health Organization staging system for HIV disease and infection in a cohort of intravenous drug users
Aylward R, Vlahov D, Muñoz A, Rapiti E. Validation of the proposed World Health Organization staging system for HIV disease and infection in a cohort of intravenous drug users. AIDS 1994, 8: 1129-1134. PMID: 7986411, DOI: 10.1097/00002030-199408000-00015.Peer-Reviewed Original ResearchConceptsIntravenous drug usersClinical stage 1Proportional hazards modelStaging systemProduct limit estimatesWorld Health OrganizationALIVE studyHIV diseaseHazards modelPopulation of IVDUWorld Health Organization (WHO) staging systemDrug usersCox proportional hazards modelStage 1WHO staging systemTime of progressionStage 2Index visitHIV seropositivityHIV-seropositivePrognostic utilityClinical stageClinical criteriaOriginal cohortClinical signsSnake bite and antivenom complications in Belo Horizonte, Brazil
Caiaffa W, Vlahov D, Antunes C, de Oliveira H, Diniz C. Snake bite and antivenom complications in Belo Horizonte, Brazil. Transactions Of The Royal Society Of Tropical Medicine And Hygiene 1994, 88: 81-85. PMID: 8154013, DOI: 10.1016/0035-9203(94)90511-8.Peer-Reviewed Original ResearchConceptsSnake biteRenal failureClinical complicationsAcute renal failureChronic renal failureTertiary referral hospitalAcute lung edemaEarly clinical complicationsAntivenom typeEarly complicationsLung edemaMuscle contracturePermanent sequelaeReferral hospitalIntracranial hemorrhageAnaphylactic reactionsAdverse reactionsHospital patientsClinical careAntivenom therapyComplicationsTissue lossGreater riskAntivenomBite
1992
Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity
Concha M, Graham N, Muñoz A, Vlahov D, Royal W, Updike M, Nance-Sproson T, Seines O, McArthur J. Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity. American Journal Of Epidemiology 1992, 136: 1338-1348. PMID: 1362630, DOI: 10.1093/oxfordjournals.aje.a116446.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsBaltimoreBlack or African AmericanCD4-Positive T-LymphocytesChronic DiseaseCognition DisordersConfounding Factors, EpidemiologicEducational StatusEmploymentEvaluation Studies as TopicFemaleHIV SeropositivityHIV SeroprevalenceHIV-1HumansLeukocyte CountLinear ModelsMaleMass ScreeningNeuropsychological TestsPopulation SurveillancePredictive Value of TestsPrisonsPsychomotor PerformanceSubstance Abuse, IntravenousConceptsNeuropsychological test performanceHIV-1 seropositivityIntravenous drug usersTest performanceNeuropsychological performancePractice effectsHuman immunodeficiency virus type 1 (HIV-1) infectionDrug usersVirus type 1 infectionSubstance abuseSignificant practice effectsHIV-1 serostatusType 1 infectionIntravenous Experience (ALIVE) studyFrequency of drugChronic substance abuseNeuropsychological functioningCognitive performanceImmunodeficiency syndromeAsymptomatic stageHigh prevalenceOutcome measuresDrug useIntoxicated individualsMultivariate analysisCharacteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use
ALCABES P, VLAHOV D, ANTHONY J. Characteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use. The Journal Of Nervous And Mental Disease 1992, 180: 48-54. PMID: 1311371, DOI: 10.1097/00005053-199201000-00010.Peer-Reviewed Original Research
1988
Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery
Lillenfeld D, Vlahov D, Tenney J, McLaughlin J. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. American Journal Of Infection Control 1988, 16: 3-6. PMID: 3369746, DOI: 10.1016/0196-6553(88)90003-x.Peer-Reviewed Original ResearchConceptsRelative riskWound infectionRisk factorsControl groupMedian sternotomy wound infectionPostoperative wound infectionIndices of obesityCardiac surgery proceduresSternotomy wound infectionDate of operationPopulation control groupOdds ratio estimatesSecond control groupUndergoing surgeryCardiac surgeryDiabetes mellitusSternotomy infectionsOperative procedureMaryland hospitalsHigh riskSurgery proceduresNursing personnelInfectionEarly signsObesity
1987
Accuracy of patient recall for date of peripheral intravenous catheter in sertion
Vlahov D, Cervino K, Standiford H. Accuracy of patient recall for date of peripheral intravenous catheter in sertion. American Journal Of Infection Control 1987, 15: 26-28. PMID: 3645973, DOI: 10.1016/0196-6553(87)90073-3.Peer-Reviewed Original Research